Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antihyperlipidaemics
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Acronyms PRECAVER
- 28 Apr 2011 Biomarkers information updated
- 27 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2010 Planned end date changed from Jun 2010 to Sep 2010 as reported by ClinicalTrials.gov.